InnovAge Raises Full-Year Guidance on Strong Q3 Revenue Growth, Adjusted EBITDA
Summary
InnovAge Holding Corp. announced its fiscal third-quarter results, reporting a 15.5% increase in total revenues to $251.9 million and a significant rise in Adjusted EBITDA to $30.5 million. Despite these operational improvements, the company posted a net loss of $29.9 million, a notable increase from the prior year's $11.1 million loss, which contrasts with the 'significant return to profitability' reported in the previous fiscal second quarter. However, management expressed confidence, citing continued operational execution and platform investments. Crucially, InnovAge raised its full-year fiscal 2026 revenue and Adjusted EBITDA guidance, signaling a positive outlook for future performance. Traders will focus on the updated guidance and strong Adjusted EBITDA growth as key indicators, despite the GAAP net loss.
At the time of this announcement, INNV was trading at $8.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.84 to $10.69. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.